EG20440A - Process for preparing of substituted pyrazoles - Google Patents

Process for preparing of substituted pyrazoles

Info

Publication number: EG20440A
Authority: EG; Egypt
Prior art keywords: preparing; substituted pyrazoles; crf; corticotropin; chem
Prior art date: 1992-12-17

Application number

EG78493A

Other languages

English (en)

Inventor

Gen M Bright

Willard M Welch

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-12-17

Filing date

1993-12-12

Publication date

1999-04-29

1993-12-12 Application filed by Pfizer filed Critical Pfizer

1999-04-29 Application granted granted Critical

1999-04-29 Publication of EG20440A publication Critical patent/EG20440A/xx

Links

238000004519 manufacturing process Methods 0.000 title 1
150000003217 pyrazoles Chemical class 0.000 title 1
102000012289 Corticotropin-Releasing Hormone Human genes 0.000 abstract 3
108010022152 Corticotropin-Releasing Hormone Proteins 0.000 abstract 3
239000000055 Corticotropin-Releasing Hormone Substances 0.000 abstract 3
208000019901 Anxiety disease Diseases 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
230000036506 anxiety Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Reproductive Health (AREA)
Virology (AREA)
AIDS & HIV (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Anesthesiology (AREA)
Transplantation (AREA)
Rheumatology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Communicable Diseases (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EG78493A 1992-12-17 1993-12-12 Process for preparing of substituted pyrazoles EG20440A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US99222892A	1992-12-17	1992-12-17

Publications (1)

Publication Number	Publication Date
EG20440A true EG20440A (en)	1999-04-29

Family

ID=25538068

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG78493A EG20440A (en)	1992-12-17	1993-12-12	Process for preparing of substituted pyrazoles

Country Status (26)

Country	Link
EP (2)	EP0959074A3 (da)
JP (1)	JP2781661B2 (da)
KR (1)	KR100190730B1 (da)
CN (1)	CN1045293C (da)
AT (1)	ATE187451T1 (da)
AU (1)	AU690079B2 (da)
BR (1)	BR9307664A (da)
CA (1)	CA2150703C (da)
CZ (1)	CZ287925B6 (da)
DE (1)	DE69327254T2 (da)
DK (1)	DK0674631T3 (da)
EG (1)	EG20440A (da)
ES (1)	ES2139676T3 (da)
FI (1)	FI111254B (da)
GR (1)	GR3032461T3 (da)
HU (1)	HUT65822A (da)
IL (1)	IL107947A (da)
MY (1)	MY109522A (da)
NO (1)	NO307884B1 (da)
NZ (1)	NZ256620A (da)
PL (1)	PL175982B1 (da)
PT (1)	PT674631E (da)
RU (1)	RU2130453C1 (da)
TW (1)	TW237455B (da)
WO (1)	WO1994013661A1 (da)
ZA (1)	ZA939406B (da)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9222253D0 (en) *	1992-10-23	1992-12-09	Celltech Ltd	Chemical compounds
GB9304919D0 (en) *	1993-03-10	1993-04-28	Celltech Ltd	Chemical compounds
GB9304920D0 (en) *	1993-03-10	1993-04-28	Celltech Ltd	Chemical compounds
NZ274978A (en) *	1993-10-12	1998-04-27	Du Pont Merck Pharma	1n-alkyl-n-aryl pyrimidinamine derivatives and pharmaceutical compositions thereof
EP0738268B1 (en) *	1993-12-22	2004-03-03	Celltech R&D Limited	Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
GB9326699D0 (en) *	1993-12-22	1994-03-02	Celltech Ltd	Chemical compounds
AU719558B2 (en) *	1994-06-06	2000-05-11	Pfizer Inc.	Substituted pyrazoles having corticotropin-releasing factor (CRF) antagonist activity
EP0764153A1 (en)	1994-06-06	1997-03-26	Pfizer Inc.	Substituted pyrazoles having corticotropin-releasing factor (crf) antagonist activity
US6245774B1 (en)	1994-06-21	2001-06-12	Celltech Therapeutics Limited	Tri-substituted phenyl or pyridine derivatives
US5786354A (en) *	1994-06-21	1998-07-28	Celltech Therapeutics, Limited	Tri-substituted phenyl derivatives and processes for their preparation
GB9412573D0 (en)	1994-06-22	1994-08-10	Celltech Ltd	Chemical compounds
GB9412571D0 (en)	1994-06-22	1994-08-10	Celltech Ltd	Chemical compounds
US6403599B1 (en)	1995-11-08	2002-06-11	Pfizer Inc	Corticotropin releasing factor antagonists
US7125880B1 (en)	1995-06-06	2006-10-24	Pfizer Inc.	Corticotropin releasing factor antagonists
GB9523675D0 (en) *	1995-11-20	1996-01-24	Celltech Therapeutics Ltd	Chemical compounds
GB9526246D0 (en) *	1995-12-21	1996-02-21	Celltech Therapeutics Ltd	Chemical compounds
GB9526245D0 (en) *	1995-12-21	1996-02-21	Celltech Therapeutics Ltd	Chemical compounds
GB9608435D0 (en) *	1996-04-24	1996-06-26	Celltech Therapeutics Ltd	Chemical compounds
US6011052A (en) *	1996-04-30	2000-01-04	Warner-Lambert Company	Pyrazolone derivatives as MCP-1 antagonists
US6124289A (en) *	1996-07-24	2000-09-26	Dupont Pharmaceuticals Co.	Azolo triazines and pyrimidines
US6060478A (en) *	1996-07-24	2000-05-09	Dupont Pharmaceuticals	Azolo triazines and pyrimidines
US6313124B1 (en)	1997-07-23	2001-11-06	Dupont Pharmaceuticals Company	Tetrazine bicyclic compounds
US6191131B1 (en)	1997-07-23	2001-02-20	Dupont Pharmaceuticals Company	Azolo triazines and pyrimidines
US7094782B1 (en)	1996-07-24	2006-08-22	Bristol-Myers Squibb Company	Azolo triazines and pyrimidines
US5861398A (en) *	1996-08-26	1999-01-19	Alanex Corporation	Benzoperimidine-carboxylic acids and derivatives thereof
GB9619284D0 (en) *	1996-09-16	1996-10-30	Celltech Therapeutics Ltd	Chemical compounds
AU4270297A (en)	1996-09-16	1998-04-02	Du Pont Pharmaceuticals Company	Pyrazinones and triazinones and their derivatives thereof
GB9622363D0 (en)	1996-10-28	1997-01-08	Celltech Therapeutics Ltd	Chemical compounds
US5760225A (en)	1996-11-15	1998-06-02	Neurogen Corporation	Certain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligands
GB9625184D0 (en) *	1996-12-04	1997-01-22	Celltech Therapeutics Ltd	Chemical compounds
AU5330698A (en)	1996-12-23	1998-07-17	Celltech Therapeutics Limited	Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
US5723608A (en) *	1996-12-31	1998-03-03	Neurogen Corporation	3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands
GB9705361D0 (en)	1997-03-14	1997-04-30	Celltech Therapeutics Ltd	Chemical compounds
ES2203937T3 (es) *	1997-03-26	2004-04-16	Taisho Pharmaceutical Co., Ltd	Derivados de 4-tetrahidropiridilpirimidina.
GB9713087D0 (en) *	1997-06-20	1997-08-27	Celltech Therapeutics Ltd	Chemical compounds
US5955471A (en) *	1998-01-13	1999-09-21	Sk Corporation	Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions containing same
US6472402B1 (en)	1998-04-02	2002-10-29	Neurogen Corporation	Aminoalkyl substituted 5,6,7,8-Tetrahydro-9H-Pyridino [2,3-B]indole derivatives
EP1068205A1 (en)	1998-04-02	2001-01-17	Neurogen Corporation	Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands
US6531475B1 (en)	1998-11-12	2003-03-11	Neurocrine Biosciences, Inc.	CRF receptor antagonists and methods relating thereto
CA2349904A1 (en)	1998-11-12	2000-05-18	Neurocrine Biosciences, Inc.	Crf receptor antagonists and methods relating thereto
DK1129091T3 (da)	1998-11-12	2002-11-04	Neurocrine Biosciences Inc	Antagonister for CRF-receptorer og fremgangsmåder med relation dertil
GB9914258D0 (en)	1999-06-18	1999-08-18	Celltech Therapeutics Ltd	Chemical compounds
US6506784B1 (en)	1999-07-01	2003-01-14	3-Dimensional Pharmaceuticals, Inc.	Use of 1,3-substituted pyrazol-5-yl sulfonates as pesticides
US6409988B1 (en)	1999-07-01	2002-06-25	3-Dimensional Pharmaceuticals, Inc.	Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligands
US6518266B1 (en)	1999-07-22	2003-02-11	3-Dimensional Pharmaceuticals	1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides
AU7865000A (en)	1999-10-06	2001-05-10	3-Dimensional Pharmaceuticals, Inc.	Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides
GB9924862D0 (en)	1999-10-20	1999-12-22	Celltech Therapeutics Ltd	Chemical compounds
TWI271406B (en)	1999-12-13	2007-01-21	Eisai Co Ltd	Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
US6569885B1 (en) *	1999-12-23	2003-05-27	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
KR20030016222A (ko) *	2000-02-14	2003-02-26	니뽄 다바코 산교 가부시키가이샤	수술후 스트레스 예방ㆍ치료제
WO2001062718A1 (en) *	2000-02-25	2001-08-30	Japan Tobacco, Inc.	Benzamide derivative and use thereof
GB0016453D0 (en) *	2000-07-04	2000-08-23	Hoffmann La Roche	Pyrrole derivatives
GB0016787D0 (en) *	2000-07-07	2000-08-30	Pfizer Ltd	Compounds useful in therapy
GB0024795D0 (en) *	2000-10-10	2000-11-22	Hoffmann La Roche	Pyrazole derivatives for the treatment of viral diseases
US20060223824A1 (en)	2000-11-28	2006-10-05	Wyeth	Serotonergic agents
US20060287335A1 (en)	2000-11-28	2006-12-21	Wyeth	Serotonergic agents for treating sexual dysfunction
TWI312347B (en)	2001-02-08	2009-07-21	Eisai R&D Man Co Ltd	Bicyclic nitrogen-containing condensed ring compounds
BR0209252A (pt)	2001-04-27	2004-07-20	Eisai Co Ltd	Pirazolo[1,5-a]piridinas e medicamentos contendo as mesmas
IL159120A0 (en)	2001-05-29	2004-05-12	Schering Ag	Cdk inhibiting pyrimidines, production thereof and their use as medicaments
IL144900A (en)	2001-08-14	2013-12-31	Neurim Pharma 1991	Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
US6638981B2 (en)	2001-08-17	2003-10-28	Epicept Corporation	Topical compositions and methods for treating pain
PT1441724E (pt) *	2001-09-27	2007-10-15	Serono Lab	Métodos para aumentar os níveis endógenos de testosterona
US7176216B2 (en)	2002-10-22	2007-02-13	Eisai Co., Ltd.	7-phenylpyrazolopyridine compounds
AU2003275589B2 (en)	2002-10-22	2009-05-28	Eisai R & D Management Co., Ltd.	7-phenyl pyrazolopyridine compounds
ES2350977T3 (es)	2002-11-05	2011-01-28	Glaxo Group Limited	Agentes antibacterianos.
EP2172197A1 (en)	2002-12-13	2010-04-07	Warner-Lambert Company LLC	Octanoic acid derivative to treat fibromyalgia and other pains
US7160888B2 (en)	2003-08-22	2007-01-09	Warner Lambert Company Llc	[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
TW200800959A (en)	2005-06-10	2008-01-01	Wyeth Corp	Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
AU2006327317B2 (en) *	2005-12-23	2010-11-25	Astrazeneca Ab	GABA-B receptor modulators
TW200817375A (en) *	2006-07-21	2008-04-16	Irm Llc	Compounds and compositions as ITPKB inhibitors
TW200901974A (en)	2007-01-16	2009-01-16	Wyeth Corp	Compounds, compositions, and methods of making and using them
MX2009013215A (es)	2007-06-15	2010-01-25	Irm Llc	Compuestos y composiciones como inhibidores de itpkb.
WO2009104080A2 (en)	2008-02-20	2009-08-27	Targia Pharmaceuticals	Cns pharmaceutical compositions and methods of use
MY152687A (en)	2008-04-15	2014-10-31	Eisai R&D Man Co Ltd	3-phenylpyrazolo[5,1-b]thiazole compound
WO2009128057A2 (en)	2008-04-18	2009-10-22	UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al	Psycho-pharmaceuticals
AR078521A1 (es)	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
DE102013002393A1 (de)	2013-02-13	2014-08-14	Rauch Landmaschinenfabrik Gmbh	Verfahren zur Regelung des Massenstromes an Streugut bei einem Scheibenstreuer
CN114716389A (zh) *	2021-12-31	2022-07-08	北京岳达生物科技有限公司	一种3,5-二乙基异恶唑-4-羧酸的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU1427781A1 (ru) *	1987-02-13	1992-04-23	Научно-исследовательский институт фармакологии АМН СССР	4-Аминокарбонил- или 4-аминоэтил-5-метилпиразолы, обладающие способностью регулировать скорость выведени этанола
US5063245A (en) *	1990-03-28	1991-11-05	Nova Pharmaceutical Corporation	Corticotropin-releasing factor antagonism compounds

1993
- 1993-09-30 KR KR1019950702479A patent/KR100190730B1/ko not_active Expired - Fee Related
- 1993-09-30 NZ NZ256620A patent/NZ256620A/en unknown
- 1993-09-30 RU RU95113965/04A patent/RU2130453C1/ru not_active IP Right Cessation
- 1993-09-30 CZ CZ19951582A patent/CZ287925B6/cs not_active IP Right Cessation
- 1993-09-30 JP JP6506653A patent/JP2781661B2/ja not_active Expired - Fee Related
- 1993-09-30 EP EP99109027A patent/EP0959074A3/en not_active Withdrawn
- 1993-09-30 ES ES93922407T patent/ES2139676T3/es not_active Expired - Lifetime
- 1993-09-30 DK DK93922407T patent/DK0674631T3/da active
- 1993-09-30 DE DE69327254T patent/DE69327254T2/de not_active Expired - Fee Related
- 1993-09-30 CA CA002150703A patent/CA2150703C/en not_active Expired - Fee Related
- 1993-09-30 PT PT93922407T patent/PT674631E/pt unknown
- 1993-09-30 AU AU51413/93A patent/AU690079B2/en not_active Ceased
- 1993-09-30 BR BR9307664A patent/BR9307664A/pt not_active Application Discontinuation
- 1993-09-30 AT AT93922407T patent/ATE187451T1/de not_active IP Right Cessation
- 1993-09-30 WO PCT/US1993/009170 patent/WO1994013661A1/en not_active Ceased
- 1993-09-30 EP EP93922407A patent/EP0674631B1/en not_active Expired - Lifetime
- 1993-10-02 TW TW082108104A patent/TW237455B/zh active
- 1993-12-09 IL IL10794793A patent/IL107947A/en not_active IP Right Cessation
- 1993-12-10 MY MYPI93002671A patent/MY109522A/en unknown
- 1993-12-12 EG EG78493A patent/EG20440A/xx active
- 1993-12-15 ZA ZA939406A patent/ZA939406B/xx unknown
- 1993-12-16 CN CN93120122A patent/CN1045293C/zh not_active Expired - Fee Related
- 1993-12-16 FI FI935672A patent/FI111254B/fi not_active IP Right Cessation
- 1993-12-16 HU HU9303615A patent/HUT65822A/hu not_active Application Discontinuation
1995
- 1995-05-31 PL PL93309355A patent/PL175982B1/pl not_active IP Right Cessation
- 1995-06-16 NO NO952397A patent/NO307884B1/no not_active IP Right Cessation
2000
- 2000-01-25 GR GR20000400155T patent/GR3032461T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0674631T3 (da)	2000-04-10
AU5141393A (en)	1994-07-04
NO952397L (no)	1995-08-14
NZ256620A (en)	1996-05-28
JP2781661B2 (ja)	1998-07-30
PT674631E (pt)	2000-04-28
KR950704299A (ko)	1995-11-17
FI111254B (fi)	2003-06-30
ZA939406B (en)	1995-06-15
IL107947A (en)	1998-08-16
IL107947A0 (en)	1994-04-12
EP0674631A1 (en)	1995-10-04
AU690079B2 (en)	1998-04-23
KR100190730B1 (ko)	1999-06-01
PL309355A1 (en)	1995-10-02
TW237455B (da)	1995-01-01
CN1093363A (zh)	1994-10-12
PL175982B1 (pl)	1999-03-31
NO952397D0 (no)	1995-06-16
NO307884B1 (no)	2000-06-13
WO1994013661A1 (en)	1994-06-23
HUT65822A (en)	1994-07-28
MY109522A (en)	1997-02-28
CN1045293C (zh)	1999-09-29
ES2139676T3 (es)	2000-02-16
JPH08500121A (ja)	1996-01-09
FI935672L (fi)	1994-06-18
DE69327254D1 (de)	2000-01-13
CZ158295A3 (en)	1995-12-13
EP0674631B1 (en)	1999-12-08
EP0959074A2 (en)	1999-11-24
CZ287925B6 (cs)	2001-03-14
ATE187451T1 (de)	1999-12-15
GR3032461T3 (en)	2000-05-31
CA2150703C (en)	2002-01-08
BR9307664A (pt)	1999-06-29
RU2130453C1 (ru)	1999-05-20
FI935672A0 (fi)	1993-12-16
DE69327254T2 (de)	2000-03-30
CA2150703A1 (en)	1994-06-23
EP0959074A3 (en)	2000-06-07

Publication	Publication Date	Title
IL107947A0 (en)	1994-04-12	Substituted pyrazoles
CA2192208A1 (en)	1995-12-14	Substituted pyrazoles
HUT55605A (en)	1991-06-28	Herbicide compositions containing diamino-triazine derivatives as active componentsand process for producing the active components
HU9302372D0 (en)	1993-10-28	Non-aromatic heterocyclic compounds containing nitrogen being substituted with substituted benzyl-amino group
NO303574B1 (no)	1998-08-03	Ny fremgangsmÕte for fremstilling av 9-amino-6-demetyl-6-deoksytetracykliner
IL107843A0 (en)	1994-04-12	Aminomethylene substituted non-aromatic heterocycles
PL322249A1 (en)	1998-01-19	1,4,5-substituted derivatives of imidazole useful as cytokin inhibitors
AU2169195A (en)	1995-12-21	Methods of administering CRF antagonists
DK0503453T3 (da)	2001-07-16	Fremgangsmåde til fremstilling af cephalosporiner og mellemprodukter i denne fremgangsmåde
PL284910A1 (en)	1991-01-14	Pesticide
DK0595111T3 (da)	1998-04-14	Carbazolonderivater og fremgangsmåde til deres fremstilling
DE3673468D1 (de)	1990-09-20	N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
MXPA02001406A (es)	2002-08-12	Heterociclilos-2h-cromenos substituidos.
ATE36318T1 (de)	1988-08-15	Verfahren zur herstellung von azetidinderivaten und zwischenprodukte.
ATE270287T1 (de)	2004-07-15	2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
MX9606166A (es)	1998-01-31	Pirazoles substituidos.
HU913055D0 (en)	1992-01-28	An improved method for producing 4-methyl-sulfonyl-benzoic acid derivatives and their intermediate products
HUT58080A (en)	1992-01-28	Process for producing imidazole derivatives
MY115291A (en)	2003-05-31	New substituted pyrazole derivatives, processes for their preparation nad their use as herbicides
CA2019255A1 (en)	1990-12-21	Process for the preparation of 4-amino, 1,2,4-triazol-5-ones
CA2272136A1 (en)	1994-06-23	Pyrazole derivatives having crf antagonist activity